References
- Chene G, Cerruto E, Moret S, et al. Quality of life after laparoscopic removal of essure sterilization devices. Eur J Obstet Gynecol Reprod Biol. 2019;3:100054.
- Miquel L, Crochet P, Francini S, et al. Laparoscopic essure device removal by en bloc Salpingectomy-Cornuectomy with intraoperative X-Ray checking: a retrospective cohort study. J Minim Invasive Gynecol. 2020;27(3):697–703.
- Maassen LW, van Gastel DM, Haveman I, et al. Removal of essure sterilization devices: a retrospective cohort study in The Netherlands. J Minim Invasive Gynecol. 2019;26(6):1056–1062.
- Johal T, Kuruba N, Sule M, et al. Laparoscopic salpingectomy and removal of essure hysteroscopic sterilisation device: a case series. Eur J Contracept Reprod Health Care. 2018;23(3):227–230.
- Lazorwitz A, Tocce K. A case series of removal of nickel-titanium sterilization microinserts from the uterine cornua using laparoscopic electrocautery for salpingectomy. Contraception. 2017;96(2):96–98.
- Parant F, Bost M, Nohuz E, et al. Potential release of toxic metal elements from essure device in symptomatic patients: first results of the french ablimco cohort. Eur J Obstet Gynecol Reprod Biol. 2020;252:434–438.
- Valle RF, Carignan CS, Wright TC. Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. Fertil Steril. 2001;76(5):974–980.
- Banet N. Clinical and histopathologic characteristics of patients undergoing surgical excision with essure coils: longitudinal experience at a women’s specialty hospital. Ann Diagn Pathol. 2020;46:151508.
- von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE)statement: guidelines for reporting observational studies. PLOS Med. 2007;4(10):e296.
- Gandek B, Ware JE, Aaronson NK, et al. Cross- validation of item selection and scoring for the SF-12 health survey of nine countries: results from the IQOLA project. International quality of life assessment. J Clin Epidemiol. 1998;51(11):1171–1178.
- Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain. 1975;1(3):277–299.
- Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97(8):734–739.
- Chene G, Cerruto E, Merviel P, et al. Surgical techniques for the removal of essure microinserts: a literature review on current practice. Eur J Contracept Reprod Health Care. 2021;26(5):404–412.
- Chene G, Vidican P, Azzi C, et al. How I do… laparoscopic removal of essure(®) device? Gynecol Obstet Fertil Senol. 2017;45(5):316–319.
- Chene G, Lebail-Carval K, Azzi C, et al. How I do… laparoscopic removal of essure(®) device by mini-cornuectomy without fragmentation? Gynecol Obstet Fertil Senol. 2018;46(7–8):608–609.
- Raison-Peyron N, Du-Thanh A, Compan C, et al. Are adverse events attributed to essure associated with nickel sensitization? Dermatitis. 2020;31(2):122–127.
- Kimber I, Basketter DA. Allergic sensitization to nickel and implanted metal devices: a perspective. Dermatitis. 2022;33(6):396–404.
- Chauhan U, Cassidy B, Tervaert JWC. ASIA (Shoenfeld’s syndrome) due to hysteroscopic essure sterilization. Autoimmun Rev. 2021;20(12):102979.
- Catinon M, Roux E, Auroux A, et al. Identification of inorganic particles resulting from degradation of ESSURE® implants: study of 10 cases. Eur J Obstet Gynecol Reprod Biol. 2020;250:162–170.
- Catinon M, Roux E, Auroux A, et al. Confirmation of the systematic presence of tin particles in fallopian tubes or uterine horns of Essure implant explanted patients: a study of 18 cases with the same pathological process. J Trace Elem Med Biol. 2022;69:126891.
- Parant F, Bost M, Nohuz E, et al. Release of metal elements from the Essure implant: a prospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2022;273:20–25.
- Aslan C, Gilbert JL. In vitro corrosion assessment of the Essure® medical device in saline, simulated inflammatory solution and neutral buffered formalin. Acta Biomater. 2022;147:414–426.
- FDA. Biological responses to metal implants. 2019. Available from: https://www.fda.gov/media/131150/download.
- Greisler HP, Henderson SC, Lam TM. Basic fibroblast growth production in vitro by macrophages exposed to dacron and polyglactin. J Biomater Sci Polym Ed. 1993;4(5):415–430.
- Rubin A, Chen JF, Veade A, et al. Pathologic findings in fallopian tubes of women with chronic pelvic pain after Essure placement. Contraception. 2020;102(2):133–136.
- Cho YK, Nguyen S, Harkins G, et al. An analysis of patients undergoind surgical removal of the Essure device: a retrospective case series. J Gynecol Surg. 2019;35(5):285–288.
- Chene G, Graesslin O. Essure implants: what’s news in the management of symptomatic patients? Gynecol Obstet Fertil Senol. 2022;50(2):105–106.